Theranostic Nanoprobes for Cancer Imaging and Therapy

When: Friday, October 11, 2013 at 1:00 pm
Where: SNL 121
Speaker: Anna Moore, PhD
Organization: Associate Professor in Radiology, Harvard Medical School
Sponsor: IGERT Nanomedicine Seminar

Molecular imaging technologies have undergone massive expansion during the previous decade and are now
posed to play crucial role in clinical oncology. In that context, development of imaging nanoprobes is
necessary for providing information on molecular signals and biomarkers of malignancies in real time, which
could aid in cancer detection and in following tumor response to chemotherapy. Nanotechnology could
potentially offer highly sensitive imaging agents capable of detecting primary tumors as well as
micrometastasis. Recent developments in theranostic nanoprobes for cancer imaging and therapy offer great
potential in cancer management. This presentation will focus on applications of nanotechnology in cancer
imaging and will address the potential of various platforms for cancer detection, staging and image‐guided